Profil
Bryan Jennings served as Chief Executive Officer & Partner at Vista Capital Advisors LLC.
He was also Head of North America Capital Markets at Morgan Stanley & Co. LLC.
Jennings served as Chief Financial Officer at KAHR Medical Ltd., Rational Vaccines, Inc., Chemomab Ltd., Peptilogics, Inc., and Beren Therapeutics PBC.
He holds an MBA from Northwestern University and an undergraduate degree from Williams College.
Anciens postes connus de Bryan Jennings
| Sociétés | Poste | Fin |
|---|---|---|
| TME PHARMA N.V. | Director of Finance/CFO | 31/12/2022 |
Peptilogics, Inc.
 Peptilogics, Inc. Miscellaneous Commercial ServicesCommercial Services Peptilogics, Inc. operates as an early-stage biotechnology company, that develops a new class of antibiotics with a novel mechanism of action derived from their eCAP (engineered cationic antibiotic peptide) platform for the treatment of multidrug-resistant infections. Its platform has the potential to produce antibiotics with broad-spectrum activity with low risk of generating resistance, due to the unique mechanism of action involving the targeted disruption of bacterial membranes. The company was founded by Jonathan Steckbeck and is headquartered in Pittsburgh, PA. | Director of Finance/CFO | 01/10/2021 |
KAHR Medical Ltd.
 KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Director of Finance/CFO | 01/06/2021 |
Beren Therapeutics PBC
 Beren Therapeutics PBC Pharmaceuticals: MajorHealth Technology Beren Therapeutics PBC is a private company based in West Hollywood, CA. The company is currently in stealth mode and more details about their operations will be available soon. The company's previous press releases indicate that they are involved in some form of therapeutic research or development. The CEO of the company is Jason Camm. | Director of Finance/CFO | 01/01/2021 |
Rational Vaccines, Inc.
 Rational Vaccines, Inc. BiotechnologyHealth Technology Rational Vaccines, Inc. engages in the provision of vaccines in treating herpes and other chronic diseases. Its products include TheravaxHSV, a therapeutic vaccine that reduce the symptoms of herpetic disease and likelihood of spread and ProfavaxHSV, a prophylactic vaccination series that offers the opportunity for recipients to acquire protective immunity against HSV-1 or HSV-2. The company was founded by William Halford and Agustin Fernandez III in 2015 and is headquartered in Cambridge, MA. | Director of Finance/CFO | 01/09/2020 |
Formation de Bryan Jennings
| Northwestern University | Masters Business Admin |
| Williams College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TME PHARMA N.V. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Finance |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Health Technology |
Vista Capital Advisors LLC
 Vista Capital Advisors LLC Investment ManagersFinance Vista Capital Advisors LLC operates as a financial product innovative company. It offers eBonds, a form of corporate bond. The company was founded by Richard K. MacAilliams and John Andrew McQuown and is headquartered in New York, NY. | Finance |
Rational Vaccines, Inc.
Rational Vaccines, Inc. BiotechnologyHealth Technology Rational Vaccines, Inc. engages in the provision of vaccines in treating herpes and other chronic diseases. Its products include TheravaxHSV, a therapeutic vaccine that reduce the symptoms of herpetic disease and likelihood of spread and ProfavaxHSV, a prophylactic vaccination series that offers the opportunity for recipients to acquire protective immunity against HSV-1 or HSV-2. The company was founded by William Halford and Agustin Fernandez III in 2015 and is headquartered in Cambridge, MA. | Health Technology |
Chemomab Ltd.
 Chemomab Ltd. BiotechnologyHealth Technology ChemomAb Ltd. develops novel chemokine blocking therapies for inflammatory and fibrotic disorders. It specializes in the development of proprietary monoclonal antibodies, directed towards novel targets, for the treatment of immune-mediated and fibrotic disorders including orphan indications. The company was founded by Adi Mor and Jacob George in 2011 and is headquartered Tel Aviv, Israel. | Health Technology |
Peptilogics, Inc.
Peptilogics, Inc. Miscellaneous Commercial ServicesCommercial Services Peptilogics, Inc. operates as an early-stage biotechnology company, that develops a new class of antibiotics with a novel mechanism of action derived from their eCAP (engineered cationic antibiotic peptide) platform for the treatment of multidrug-resistant infections. Its platform has the potential to produce antibiotics with broad-spectrum activity with low risk of generating resistance, due to the unique mechanism of action involving the targeted disruption of bacterial membranes. The company was founded by Jonathan Steckbeck and is headquartered in Pittsburgh, PA. | Commercial Services |
Beren Therapeutics PBC
Beren Therapeutics PBC Pharmaceuticals: MajorHealth Technology Beren Therapeutics PBC is a private company based in West Hollywood, CA. The company is currently in stealth mode and more details about their operations will be available soon. The company's previous press releases indicate that they are involved in some form of therapeutic research or development. The CEO of the company is Jason Camm. | Health Technology |
